BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3546237)

  • 1. Induction of antitumor resistance to mouse leukemia L1210 by spergualins.
    Ishizuka M; Masuda T; Mizutani S; Osono M; Kumagai H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Dec; 39(12):1736-43. PubMed ID: 3546237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of cytotoxic T-lymphocytes in the antitumor activity of spergualin against L1210 cells.
    Umezawa H; Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T
    Cancer Res; 1987 Jun; 47(12):3062-5. PubMed ID: 3495325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivo.
    Harrison SD; Brockman RW; Trader MW; Laster WR; Griswold DP
    Invest New Drugs; 1987 Dec; 5(4):345-51. PubMed ID: 3436739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of spergualin analogues. I.
    Nishizawa R; Takei Y; Yoshida M; Tomiyoshi T; Saino T; Nishikawa K; Nemoto K; Takahashi K; Fujii A; Nakamura T
    J Antibiot (Tokyo); 1988 Nov; 41(11):1629-43. PubMed ID: 3242505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro immunosuppressive properties of spergualins to murine T cell response.
    Fujii H; Takada T; Nemoto K; Abe F; Fujii A; Takeuchi T
    J Antibiot (Tokyo); 1989 May; 42(5):788-94. PubMed ID: 2524464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spergualin, a new antitumor antibiotic].
    Takeuchi T
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):845-9. PubMed ID: 3566295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spergualin: a new antitumour antibiotic.
    Umezawa K; Takeuchi T
    Biomed Pharmacother; 1987; 41(5):227-32. PubMed ID: 3499181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunomodulation by antitumor antibiotics].
    Ishizuka M
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):697-700. PubMed ID: 3963840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of spergualin, a novel antitumor antibiotic.
    Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Oct; 39(10):1461-6. PubMed ID: 3781914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of (-)-15-deoxyspergualin and (-)-spergualin-15-phosphate.
    Iwasawa H; Kondo S; Ikeda D; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1982 Dec; 35(12):1665-9. PubMed ID: 6926749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new antitumor antibiotic, spergualin: isolation and antitumor activity.
    Takeuchi T; Iinuma H; Kunimoto S; Masuda T; Ishizuka M; Takeuchi M; Hamada M; Naganawa H; Kondo S; Umezawa H
    J Antibiot (Tokyo); 1981 Dec; 34(12):1619-21. PubMed ID: 7333976
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor spectrum of deoxyspergualin and its lack of cross-resistance to other antitumor agents.
    Nishikawa K; Shibasaki C; Hiratsuka M; Arakawa M; Takahashi K; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1101-9. PubMed ID: 1955393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumor activity of spergualin analogues. III. Novel method for synthesis of optically active 15-deoxyspergualin and 15-deoxy-11-O-methylspergualin.
    Umeda Y; Moriguchi M; Ikai K; Kuroda H; Nakamura T; Fujii A; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1987 Sep; 40(9):1316-24. PubMed ID: 3680041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxyspergualin inhibits cytotoxic T lymphocytes but not NK or LAK cells.
    Kerr PG; Atkins RC
    Immunol Cell Biol; 1991 Jun; 69 ( Pt 3)():177-83. PubMed ID: 1835710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T
    Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210.
    Rahman SM; Kawashima K; Nakashima I; Nagase F
    Cancer Res; 1988 Nov; 48(22):6450-4. PubMed ID: 3263189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive activity of 15-deoxyspergualin and its effect on skin allografts in rats.
    Masuda T; Mizutani S; Iijima M; Odai H; Suda H; Ishizuka M; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1987 Nov; 40(11):1612-8. PubMed ID: 3693129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of forphenicinol on the production of Ia-positive macrophages in mice with or without L1210 leukemia and on the growth of L1210 in immunized mice.
    Okura A; Arakawa H; Yoshinari T; Naito K; Ishizuka M; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Apr; 39(4):575-80. PubMed ID: 3458691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of T-lymphocytes in the curative effect of a novel synthetic polyamine analogue, N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine, against L1210 leukemia in vivo.
    Bowlin TL; Prakash NJ; Edwards ML; Sjoerdsma A
    Cancer Res; 1991 Jan; 51(1):62-6. PubMed ID: 1988107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
    Ujiie T
    Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.